Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology
Authors
Keywords
-
Journal
Alzheimers Research & Therapy
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-09-28
DOI
10.1186/s13195-020-00682-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ATN classification and clinical progression in subjective cognitive decline
- (2020) Jarith L. Ebenau et al. NEUROLOGY
- Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer’s Disease and Correlates with Cognitive Impairment
- (2019) Patrick Oeckl et al. JOURNAL OF ALZHEIMERS DISEASE
- Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease
- (2019) Oliver Preische et al. NATURE MEDICINE
- Potential Value of Plasma Amyloid-β, Total Tau, and Neurofilament Light for Identification of Early Alzheimer’s Disease
- (2019) Yachen Shi et al. ACS Chemical Neuroscience
- Brain Amyloid-β Deposition and Blood Biomarkers in Patients with Clinically Diagnosed Alzheimer’s Disease
- (2019) Wei-Wei Li et al. JOURNAL OF ALZHEIMERS DISEASE
- High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis
- (2019) Suzanne E. Schindler et al. NEUROLOGY
- Plasma and CSF neurofilament light
- (2019) Michelle M. Mielke et al. NEUROLOGY
- Neurofilament light chain plasma concentration predicts neurodegeneration and clinical progression in nondemented elderly adults
- (2019) Hao Hu et al. Aging-US
- Discordant amyloid-β PET and CSF biomarkers and its clinical consequences
- (2019) Arno de Wilde et al. Alzheimers Research & Therapy
- Ultrasensitive Detection of Plasma Amyloid-β as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer’s Disease
- (2019) Pratishtha Chatterjee et al. JOURNAL OF ALZHEIMERS DISEASE
- CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia
- (2019) Samir Abu-Rumeileh et al. Alzheimers Research & Therapy
- Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography
- (2018) Michelle M. Mielke et al. Alzheimers & Dementia
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Amyloid blood biomarker detects Alzheimer's disease
- (2018) Andreas Nabers et al. EMBO Molecular Medicine
- Amsterdam Dementia Cohort: Performing Research to Optimize Care
- (2018) Wiesje M. van der Flier et al. JOURNAL OF ALZHEIMERS DISEASE
- High performance plasma amyloid-β biomarkers for Alzheimer’s disease
- (2018) Akinori Nakamura et al. NATURE
- Association of Amyloid Positron Emission Tomography With Changes in Diagnosis and Patient Treatment in an Unselected Memory Clinic Cohort
- (2018) Arno de Wilde et al. JAMA Neurology
- Plasma amyloid as pre-screener for the earliest Alzheimer's pathological changes
- (2018) Inge M.W. Verberk et al. ANNALS OF NEUROLOGY
- Optimizing Patient Care and Research: The Amsterdam Dementia Cohort
- (2018) Wiesje M. van der Flier et al. JOURNAL OF ALZHEIMERS DISEASE
- Neurofilaments as biomarkers in neurological disorders
- (2018) Michael Khalil et al. Nature Reviews Neurology
- Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
- (2018) Piotr Lewczuk et al. Alzheimers Research & Therapy
- Subjective Cognitive Impairment Cohort (SCIENCe): study design and first results
- (2018) Rosalinde E. R. Slot et al. Alzheimers Research & Therapy
- Interlaboratory proficiency processing scheme in CSF aliquoting: implementation and assessment based on biomarkers of Alzheimer’s disease
- (2018) Piotr Lewczuk et al. Alzheimers Research & Therapy
- A two-step immunoassay for the simultaneous assessment of Aβ38, Aβ40 and Aβ42 in human blood plasma supports the Aβ42/Aβ40 ratio as a promising biomarker candidate of Alzheimer’s disease
- (2018) Hedieh Shahpasand-Kroner et al. Alzheimers Research & Therapy
- Neurotoxic reactive astrocytes are induced by activated microglia
- (2017) Shane A. Liddelow et al. NATURE
- Serum neurofilament light in familial Alzheimer disease
- (2017) Philip S.J. Weston et al. NEUROLOGY
- Review: Astrocytes in Alzheimer's disease and other age-associated dementias: a supporting player with a central role
- (2017) C. J. Garwood et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Plasma neurofilament light chain levels in Alzheimer’s disease
- (2017) Wenjun Zhou et al. NEUROSCIENCE LETTERS
- Diagnostic impact of [18F]flutemetamol PET in early-onset dementia
- (2017) Marissa D. Zwan et al. Alzheimers Research & Therapy
- Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease
- (2017) Niklas Mattsson et al. JAMA Neurology
- Glial Fibrillary Acidic Protein and Protein S-100B: Different Concentration Pattern of Glial Proteins in Cerebrospinal Fluid of Patients with Alzheimer's Disease and Creutzfeldt-Jakob Disease
- (2017) Sarah Jesse et al. JOURNAL OF ALZHEIMERS DISEASE
- Profiling the human hippocampal proteome at all pathologic stages of Alzheimer's disease
- (2016) David C. Hondius et al. Alzheimers & Dementia
- Alzheimer's disease
- (2016) Philip Scheltens et al. LANCET
- Plasma β-amyloid in Alzheimer’s disease and vascular disease
- (2016) Shorena Janelidze et al. Scientific Reports
- Alzheimer’s disease cerebrospinal fluid biomarker in cognitively normal subjects
- (2015) Jon B. Toledo et al. BRAIN
- Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer's disease, dementia with Lewy bodies, and frontotemporal lobar degeneration
- (2015) Aiko Ishiki et al. JOURNAL OF NEUROCHEMISTRY
- A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
- (2014) Frank Jessen et al. Alzheimers & Dementia
- Long-term effects of amyloid, hypometabolism, and atrophy on neuropsychological functions
- (2014) R. Ossenkoppele et al. NEUROLOGY
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
- (2012) Randall J. Bateman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative
- (2011) Hugo Vanderstichele et al. Alzheimers & Dementia
- Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain
- (2008) J.E. Simpson et al. NEUROBIOLOGY OF AGING
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now